Hutchinson, Peter J.
Kolias, Angelos G.
Tajsic, Tamara
Adeleye, Amos
Aklilu, Abenezer Tirsit
Apriawan, Tedy
Bajamal, Abdul Hafid
Barthélemy, Ernest J.
Devi, B. Indira
Bhat, Dhananjaya
Bulters, Diederik
Chesnut, Randall
Citerio, Giuseppe
Cooper, D. Jamie
Czosnyka, Marek
Edem, Idara
El-Ghandour, Nasser M.F.
Figaji, Anthony
Fountas, Kostas N.
Gallagher, Clare
Hawryluk, Gregory W.J.
Iaccarino, Corrado
Joseph, Mathew
Khan, Tariq
Laeke, Tsegazeab
Levchenko, Oleg
Liu, Baiyun
Liu, Weiming
Maas, Andrew
Manley, Geoffrey T.
Manson, Paul
Mazzeo, Anna T.
Menon, David K.
Michael, Daniel B.
Muehlschlegel, Susanne
Okonkwo, David O.
Park, Kee B.
Rosenfeld, Jeffrey V.
Rosseau, Gail
Rubiano, Andres M.
Shabani, Hamisi K.
Stocchetti, Nino
Timmons, Shelly D.
Timofeev, Ivan
Uff, Chris
Ullman, Jamie S.
Valadka, Alex
Waran, Vicknes
Wells, Adam
Wilson, Mark H.
Servadei, Franco
Funding for this research was provided by:
University of Cambridge
Article History
Received: 15 April 2019
Accepted: 29 April 2019
First Online: 28 May 2019
Compliance with ethical standards
:
: Peter J. Hutchinson is the Chief Investigator of the RESCUEicp and RESCUE-ASDH randomised trials. Giuseppe Citerio has received honoraria for serving as a speaker from Codman/Integra and Neurooptics. D. Jamie Cooper is the Chief Investigator for the DECRA trial. Marek Czosnyka receives part of licencing fee Part of licensing fee for ICM+ Software (Cambridge Enterprise Ltd). Corrado Iaccarino has a consultant contract for post-market Surveillance for FINCERAMICA S.p.A. Franco Servadei has received personal fees from Takeda Pharmaceutical Company, grants and personal fees from Integra LifeSciences, and grants and personal fees from Finceramica SpA. The rest of the authors declare that they have no conflict of interest related to this manuscript.
: This article does not contain any studies with human participants performed by any of the authors.